Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pancreatic Neoplasms × IFL protocol × Clear all

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 15 Neoplasm Metastasis 5 Neoplasms 4 Colonic Neoplasms 4 Stomach Neoplasms 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Gastrointestinal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Neoplasms 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Gastroesophageal Adenocarcinoma 1 Endometrial Neoplasms 1

Interventions

Gemcitabine 151 130-nm albumin-bound paclitaxel 48 Albumin-Bound Paclitaxel 37 Oxaliplatin 29 Fluorouracil 29 Capecitabine 29 pembrolizumab 28 Radiotherapy 25 Leucovorin 25 Irinotecan 25 Erlotinib Hydrochloride 21 Nivolumab 20 Cisplatin 18 Taxes 17 Bevacizumab 14 Radiosurgery 11 Cyclophosphamide 11 Specimen Handling 10 Magnetic Resonance Spectroscopy 10 Carboplatin 10 Paclitaxel 9 Docetaxel 9 Sorafenib 8 Ipilimumab 8 Biopsy 8 trametinib 7 poly ICLC 7 olaparib 7 folfirinox 7 fludarabine 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04270929 2021-06-01

PANC-001

Roger Williams Medical Center

Phase 1 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡